Toni K. Choueiri, Todd Michael Bauer, Jaime R. Merchan, David F. McDermott, Robert A. Figlin, Edward Arrowsmith, M. Dror Michaelson, Elisabeth I. Heath, Anishka D’Souza, Song Zhao, Laurent Kassalow, Rodolfo F. Perini, Donna Vickery, Scott S. Tykodi. "Updated results from the phase 2 LITESPARK-003 study of belzutifan plus cabozantinib in patients with advanced clear cell renal cell carcinoma (ccRCC).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.5_suppl.549